The federal contract award SPE2DB22D3016|SPE2DB25FAHA4, valued at $23,905.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,770,435 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm fixed-price delivery order contract with a completion date of December 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 3/20/25, 9:57 AM